Dr. Sangeetha Bhatia: Won $2,50,000 Heinz Award for developing World's First Micro-Liver Cells

Photo: Bryce Vickmark
Dr. Sangeeta Bhatia     
20th Heinz Award for Technology,the Economy and Employment

Dr. Sangeeta Bhatia, bioengineer at the Massachusetts Institute of Technology, is recognized for her seminal work in tissue engineering and disease detection, including the cultivation of functional liver cells outside the human body.

As a graduate student at MIT, Dr. Bhatia was assigned the task of cultivating living liver cells in a petri dish, an endeavor that had been attempted for many years. A visit to a microfabrication facility — where students laid circuits out on silicon chips — inspired her to see if the same technology could be used to “print” tiny liver cells on plastic. The result was the first “microliver,” a miniature model organ now widely used to test drug reactions efficiently and predictively.

Dr. Bhatia’s team has also made singular strides in developing simple, affordable cancer screening tools. One uses tiny particles or nanoparticles to create biomarkers for cancer in urine samples on paper strips; the other is a “cancer-detecting yogurt,” containing engineered probiotic bacteria.
She is a strong proponent for gender diversity in the sciences, having co-founded a national college campus outreach program to attract young girls to engineering.



Read the article published about Dr. Sangeetha Bhatia's work published in MIT Review
Her discoveries have opened new pathways within human health research, and her passionate advocacy continues to expand possibilities for future generations in her field.


Courtesy by: www.thebetterindia.com
“These remarkable men and women come from different fieldsand diverse backgrounds, but they share a bedrock conviction in their abilityand responsibility as individuals to make a transformative impacton the world and the lives of others.
-Teresa Heinz


0 comentários:

Post a Comment